Products
Substances
About Database
In this article, you will learn about the methodology for assigning the status of a cellular chronoblocker or proresilient
The database may include a substance, product or technology that has proven efficacy in the primary and secondary prevention of proxy diseases of aging and in enhancing the associated adaptive mechanisms.
Based on the submitted materials, as well as the available global evidence base, an international expert commission identifies the targeting of a substance (product, technology) in relation to specific proxy diseases of aging.
Based on the submitted materials, as well as the available global evidence base, an international expert commission identifies the targeting of a substance (product, technology) in relation to specific proxy diseases of aging.